Paul Szabolcs

This study tests a stem cell transplant for people with common variable immunodeficiency (CVID) and other immune disorders. It aims to replace faulty immune cells with healthy donor cells to control the disease. Participants are aged 5 to 40 and receive a reduced-intensity transp…

This study tests a milder chemotherapy and transplant method for children and young adults up to age 55 with serious non-cancer blood disorders like immune deficiencies, anemias, and metabolic diseases. The goal is to see if this gentler approach can safely replace the patient's …

This study tests a stem cell transplant using the patient's own blood cells for young people (ages 8-24) with severe scleroderma that hasn't improved with standard treatments. The goal is to see if this high-dose therapy is safe and can control the disease better than current med…

This early-phase study tests whether a lung transplant followed by a bone marrow transplant can help people with severe lung disease and bone marrow failure. Up to 8 adults aged 18-60 with conditions like pulmonary fibrosis or COPD will receive a lung transplant first, then a bon…